Navigation Links
Neurocrine Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
Date:10/26/2010

SAN DIEGO, Oct. 26 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Oppenheimer 21st Annual Healthcare Conference in New York.  

The live presentation takes place on Tuesday, November 2, 2010 at 11:25 a.m. Eastern Time / 8:25 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
2. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results
3. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
4. Neurocrine Biosciences to Present at the Deutsche Bank 35th Annual Health Care Conference
5. Neurocrine Biosciences to Present at the 30th Annual Cowen & Co. Health Care Conference
6. Neurocrine Biosciences, Inc. Prices Common Stock Offering
7. Neurocrine Announces Proposed Public Offering of Common Stock
8. Neurocrine Advances VMAT2 Inhibitor Program
9. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
10. Neurocrine Biosciences Reports Third Quarter 2009 Results
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... , Aug. 17, 2017 MJAC2017 , the ... Canna Broadcast Media, today reveals its leading lineup. ... Inc., a global cannabis innovator specializing in the development of ... the conference. MassRoots, Rambridge™ and The Green Organic Dutchman are ... and Namaste Vapes™ as silver sponsors. ...
(Date:8/15/2017)... Mich. , Aug. 15, 2017 Diplomat ... naloxone to Michigan residents. ... Flint retail pharmacy, G-3320 Beecher ... approved by the Food and Drug Administration, is intended ... extreme drowsiness, slowed breathing, and loss of consciousness. The ...
(Date:8/14/2017)... Israel , Aug. 15, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced financial ... "We are in ... 3 trial to investigate NurOwn ® in ALS," ... Officer of BrainStorm. "We have agreements with Mass. General ...
Breaking Medicine Technology:
(Date:8/18/2017)... Thailand (PRWEB) , ... August 19, 2017 , ... ... Business, Tourism Authority of Thailand presided over the Amazing Thailand Health and Wellness ... in Thailand. , Mr. Noppadon Pakprot, Deputy Governor for Tourism Products and Business ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... For Immediate Release                Contact: Julian Teixeira, August 18, 2017                    202-478-8564 / jteixeira@thenc.org ... Advice from their Fathers , Contrary to a father’s ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... “Vision & Hearing” campaign, advocating for active, healthy lifestyles and highlighting the importance ... for individuals with hearing impairments and shares the latest innovations in hearing aid ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet ... advocating for active, healthy lifestyles and highlighting the importance of proactive eye and ... impairments and shares the latest innovations in hearing aid technology. , In ...
(Date:8/18/2017)... , ... August 18, 2017 , ... The Dawn Johnson ... inaugurating a new charity drive to generate community support for efforts to educate the ... cures and treatments for all types of cancer. , Each day in America, ...
Breaking Medicine News(10 mins):